Categories: News

Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) — Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.

Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, December 17th with the first live webcast at 9:30 AM ET.

REGISTER NOW AT: https://bit.ly/3oTRSRH

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.

Agenda and presenting companies:

Eastern Time
(ET)
Company Name Ticker(s)
9:30 AM Kane Biotech Inc. OTCQB: KNBIF | TSX-V: KNE
10:00 AM Theralase Technologies Inc. OTCQB: TLTFF | TSX-V: TLT
10:30 AM Caladrius Biosciences, Inc. NASDAQ: CLBS
11:00 AM Pressure BioSciences, Inc. OTCQB: PBIO
11:30 AM HLS Therapeutics Inc. TSX: HLS
12:00 PM Bionexus Gene Lab Corp. OTCQB: BGLC
12:30 PM VolitionRx Limited NYSE AMERICAN: VNRX
1:00 PM XPhyto Therapeutics Corp. OTCQB: XPHYF | CSE: XPHY | FSE: 4XT

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACT: CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com

Staff

Recent Posts

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

4 hours ago

After Trump’s Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ’s Writ of Mandamus?

After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…

22 hours ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

1 day ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

1 day ago

Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients

Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…

1 day ago